Open AccessFactors associated with the presence of abnormal levels of fecal calprotectin in patients with negative panenteric studies
Author(s) -
Juan Egea Valenzuela,
E. Jorquera,
Francisco Javier Álvarez-Higueras,
María Muñoz Tornero,
Ana Pereñíguez López,
E. Diez,
Fernando Alberca de las Parras
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.6508/2019
Subject(s) - calprotectin , medicine , feces , gastroenterology , physiology , microbiology and biotechnology , inflammatory bowel disease , disease , biology
fecal calprotectin is a selection tool prior to endoscopic studies in patients with gastrointestinal symptoms. However, some symptomatic patients with altered fecal calprotectin will not have any endoscopic lesions. The aim of the study was to determine the factors associated with the presence of altered fecal calprotectin in patients with negative endoscopic studies of the colon and small bowel.